Lomitapide
| CAS No. | 182431-12-5 |
|---|---|
| MDL No. | MFCD16620494 |
| MF | C39H37F6N3O2 |
| MW | 693.70 |
| InChI Key | MBBCVAKAJPKAKM-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Lomitapide is a benzamide formed by the formal condensation of the carboxy group of 4'-(trifluoromethyl)biphenyl-2-carboxylic acid with the primary amino group of 9-[4-(4-aminopiperidin-1-yl)butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide. It is used as its mesylate salt in conjunction with a low-fat diet and other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia. It functions as an anticholesteremic drug and MTP inhibitor. It belongs to piperidines, fluorenes, benzamides, and (trifluoromethyl)benzenes. It is the conjugate base of lomitapide(1+).
| CAS No. | 182431-12-5 |
|---|---|
| Product Name | Lomitapide |
Biological Targets
MTTP·P4HB
Associated Conditions
homozygous familial hypercholesterolemia·hyperlipidemia·familial hypercholesterolemia·Hypercholesterolemia·cardiovascular disease
* The information provided here is compiled from public sources and is for reference only.
